E Fund Management (HK)’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$36.3K Buy
420
+416
+10,400% +$37K 0.01% 285
2026
Q2
$362 Hold
4
– – ﹤0.01% 535
2026
Q1
$320 Hold
4
– – ﹤0.01% 474
2025
Q4
$331 Hold
4
– – ﹤0.01% 370
2025
Q3
$311 Buy
+4
New +$313 ﹤0.01% 334

Other funds holding EW

E Fund Management (HK)'s EW Position: Q3 2026 in Review

E Fund Management (HK) increased its Edwards Lifesciences (EW) stake by 10,400% in Q3 2026, buying an estimated $37K and bringing the position to 420 shares worth $36.3K. The position accounts for 0.01% of the portfolio, ranked #285.

E Fund Management (HK) first reported a position in EW in Q3 2025 and has held it in 5 quarters since. 1,345 funds tracked by Wall St. Rank hold EW as of Q3 2026.

  • E Fund Management (HK) held 420 shares of Edwards Lifesciences worth $36.3K as of Q3 2026.
  • E Fund Management (HK) bought 416 Edwards Lifesciences shares in Q3 2026, an estimated $37K.
  • Edwards Lifesciences made up 0.01% of E Fund Management (HK)'s portfolio in Q3 2026, its #285 holding.
  • E Fund Management (HK) first reported a position in Edwards Lifesciences in Q3 2025 and has held it in 5 quarters since.
  • 1,345 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on E Fund Management (HK)'s 13F filing for Q3 2026, filed 12 Nov 2026.